These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1010 related articles for article (PubMed ID: 22130357)
1. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways. Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357 [TBL] [Abstract][Full Text] [Related]
2. Promotion of direct angiogenesis in vitro and in vivo by Puerariae flos extract via activation of MEK/ERK-, PI3K/Akt/eNOS-, and Src/FAK-dependent pathways. Chung BH; Cho YL; Kim JD; Jo HS; Won MH; Lee H; Ha KS; Kwon YG; Kim YM Phytother Res; 2010 Jun; 24(6):934-40. PubMed ID: 19960515 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
4. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629 [TBL] [Abstract][Full Text] [Related]
5. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665 [TBL] [Abstract][Full Text] [Related]
6. Gleditsioside B, a triterpene saponin isolated from the anomalous fruits of Gleditsia sinensis Lam., abrogates bFGF-induced endothelial cell migration through preventing the activation of MMP-2 and FAK via inhibiting ERK and PI3K/AKT signaling pathways. Tong B; Lu D; Wei Z; Wang T; Xia Y; Dai Y Vascul Pharmacol; 2013 Jan; 58(1-2):118-26. PubMed ID: 23026290 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells. Kim SJ; Kim SY; Kwon CH; Kim YK Growth Factors; 2007 Apr; 25(2):77-86. PubMed ID: 17852407 [TBL] [Abstract][Full Text] [Related]
8. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways. Park JH; Ryu JM; Han HJ J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539 [TBL] [Abstract][Full Text] [Related]
9. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways. Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854 [TBL] [Abstract][Full Text] [Related]
10. Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression. Chiang JK; Sung ML; Yu HR; Chang HI; Kuo HC; Tsai TC; Yen CK; Chen CN J Cell Physiol; 2011 Apr; 226(4):1017-26. PubMed ID: 20857402 [TBL] [Abstract][Full Text] [Related]
11. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade. Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730 [TBL] [Abstract][Full Text] [Related]
12. Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways. Jin YJ; Lee JH; Kim YM; Oh GT; Lee H Cell Signal; 2012 Aug; 24(8):1485-95. PubMed ID: 22484283 [TBL] [Abstract][Full Text] [Related]
14. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer. Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694 [TBL] [Abstract][Full Text] [Related]
15. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806 [TBL] [Abstract][Full Text] [Related]
16. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling. Wang J; Zhao Y; Kauss MA; Spindel S; Lian H Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874 [TBL] [Abstract][Full Text] [Related]
17. Osteogenesis and angiogenesis induced by porous β-CaSiO(3)/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways. Wang C; Lin K; Chang J; Sun J Biomaterials; 2013 Jan; 34(1):64-77. PubMed ID: 23069715 [TBL] [Abstract][Full Text] [Related]
18. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells. Kim GD; Oh J; Jeong LS; Lee SK Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876 [TBL] [Abstract][Full Text] [Related]
19. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
20. Involvement of Cx43 phosphorylation in 5'-N-ethylcarboxamide-induced migration and proliferation of mouse embryonic stem cells. Kim MO; Lee YJ; Han HJ J Cell Physiol; 2010 Jul; 224(1):187-94. PubMed ID: 20232318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]